Matches in SemOpenAlex for { <https://semopenalex.org/work/W2078484622> ?p ?o ?g. }
- W2078484622 endingPage "903" @default.
- W2078484622 startingPage "889" @default.
- W2078484622 abstract "Introduction: The inhibition of the epidermal growth factor receptor (EGFR) through tyrosine kinase inhibitors (TKIs) represents an effective strategy for EGFR-mutated NSCLC. Afatinib is an irreversible erythroblastosis oncogene B (ErbB) family blocker, able to inhibit the kinase domains of EGFR, HER2 and HER4, and the transphosphorylation of ErbB3 that has recently been approved in the United States for the first-line treatment of EGFR-mutated NSCLC and in Europe and Japan for the treatment of EGFR-mutated TKI-naive patients. Areas covered: The authors analyzed the pharmacology and the clinical activity of afatinib in NSCLC through a review of the literature. Trials exploring different settings have been reported, including LUX-Lung 3 and LUX-Lung 6, where the drug achieved better outcomes in terms of response rate, progression-free survival and quality of life compared with chemotherapy. The main toxicities of afatinib are gastrointestinal and skin-related adverse events. Expert opinion: Afatinib showed remarkable efficacy as a first-line treatment in the presence of common EGFR mutations. Afatinib showed some activity in NSCLC with acquired resistance to EGFR TKIs, although, currently, its efficacy after the failure of erlotinib or gefitinib has not been clearly stated. Direct clinical data comparing the activity and tolerability of different inhibitors are still needed." @default.
- W2078484622 created "2016-06-24" @default.
- W2078484622 creator A5001753228 @default.
- W2078484622 creator A5030531642 @default.
- W2078484622 creator A5032477448 @default.
- W2078484622 creator A5035375963 @default.
- W2078484622 creator A5036706220 @default.
- W2078484622 creator A5043174098 @default.
- W2078484622 creator A5043775758 @default.
- W2078484622 creator A5069883266 @default.
- W2078484622 creator A5073079268 @default.
- W2078484622 creator A5086247944 @default.
- W2078484622 creator A5089907220 @default.
- W2078484622 date "2014-03-19" @default.
- W2078484622 modified "2023-10-18" @default.
- W2078484622 title "Afatinib for the treatment of advanced non-small-cell lung cancer" @default.
- W2078484622 cites W1487852212 @default.
- W2078484622 cites W1977449846 @default.
- W2078484622 cites W1979235563 @default.
- W2078484622 cites W1982953340 @default.
- W2078484622 cites W1989931815 @default.
- W2078484622 cites W1997852270 @default.
- W2078484622 cites W2013573900 @default.
- W2078484622 cites W2014484940 @default.
- W2078484622 cites W2022392694 @default.
- W2078484622 cites W2022971046 @default.
- W2078484622 cites W2028468177 @default.
- W2078484622 cites W2057145505 @default.
- W2078484622 cites W2062869295 @default.
- W2078484622 cites W2063056853 @default.
- W2078484622 cites W2063391304 @default.
- W2078484622 cites W2071539936 @default.
- W2078484622 cites W2073901381 @default.
- W2078484622 cites W2079251910 @default.
- W2078484622 cites W2095618958 @default.
- W2078484622 cites W2096198395 @default.
- W2078484622 cites W2098549466 @default.
- W2078484622 cites W2099180737 @default.
- W2078484622 cites W2100496118 @default.
- W2078484622 cites W2112602910 @default.
- W2078484622 cites W2114095518 @default.
- W2078484622 cites W2117676712 @default.
- W2078484622 cites W2125760261 @default.
- W2078484622 cites W2126696135 @default.
- W2078484622 cites W2132540363 @default.
- W2078484622 cites W2137907451 @default.
- W2078484622 cites W2138851777 @default.
- W2078484622 cites W2138993970 @default.
- W2078484622 cites W2143573503 @default.
- W2078484622 cites W2143913849 @default.
- W2078484622 cites W2152905269 @default.
- W2078484622 cites W2153156618 @default.
- W2078484622 cites W2159013299 @default.
- W2078484622 cites W2160336497 @default.
- W2078484622 cites W2161940278 @default.
- W2078484622 cites W2166084034 @default.
- W2078484622 cites W2171139285 @default.
- W2078484622 cites W2185481272 @default.
- W2078484622 cites W2332183914 @default.
- W2078484622 cites W2561609744 @default.
- W2078484622 cites W2598397779 @default.
- W2078484622 cites W2600898673 @default.
- W2078484622 cites W2607223419 @default.
- W2078484622 cites W2957137166 @default.
- W2078484622 doi "https://doi.org/10.1517/14656566.2014.902445" @default.
- W2078484622 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24646054" @default.
- W2078484622 hasPublicationYear "2014" @default.
- W2078484622 type Work @default.
- W2078484622 sameAs 2078484622 @default.
- W2078484622 citedByCount "20" @default.
- W2078484622 countsByYear W20784846222014 @default.
- W2078484622 countsByYear W20784846222015 @default.
- W2078484622 countsByYear W20784846222016 @default.
- W2078484622 countsByYear W20784846222017 @default.
- W2078484622 countsByYear W20784846222018 @default.
- W2078484622 countsByYear W20784846222020 @default.
- W2078484622 countsByYear W20784846222021 @default.
- W2078484622 crossrefType "journal-article" @default.
- W2078484622 hasAuthorship W2078484622A5001753228 @default.
- W2078484622 hasAuthorship W2078484622A5030531642 @default.
- W2078484622 hasAuthorship W2078484622A5032477448 @default.
- W2078484622 hasAuthorship W2078484622A5035375963 @default.
- W2078484622 hasAuthorship W2078484622A5036706220 @default.
- W2078484622 hasAuthorship W2078484622A5043174098 @default.
- W2078484622 hasAuthorship W2078484622A5043775758 @default.
- W2078484622 hasAuthorship W2078484622A5069883266 @default.
- W2078484622 hasAuthorship W2078484622A5073079268 @default.
- W2078484622 hasAuthorship W2078484622A5086247944 @default.
- W2078484622 hasAuthorship W2078484622A5089907220 @default.
- W2078484622 hasConcept C121608353 @default.
- W2078484622 hasConcept C126322002 @default.
- W2078484622 hasConcept C143998085 @default.
- W2078484622 hasConcept C197934379 @default.
- W2078484622 hasConcept C2776232967 @default.
- W2078484622 hasConcept C2776256026 @default.
- W2078484622 hasConcept C2777930144 @default.
- W2078484622 hasConcept C2778087573 @default.
- W2078484622 hasConcept C2778375690 @default.